tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRBP Stock Latest News

Corbus Pharmaceuticals Completes $75 Million Public Offering
Company AnnouncementsCorbus Pharmaceuticals Completes $75 Million Public Offering
43m ago
8K
CRBP
Corbus Pharmaceuticals sees cash runway into 2028
PremiumThe Fly
Corbus Pharmaceuticals sees cash runway into 2028
1h ago
CRBP
Corbus Pharmaceuticals reports Q3 EPS ($1.90), consensus ($1.71)
PremiumThe Fly
Corbus Pharmaceuticals reports Q3 EPS ($1.90), consensus ($1.71)
1h ago
CRBP
CRBP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRBP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
CRBP
Corbus Pharmaceuticals management to meet virtually with B. Riley
PremiumThe Fly
Corbus Pharmaceuticals management to meet virtually with B. Riley
6d ago
CRBP
Corbus Pharmaceuticals management to meet virtually with B. Riley
PremiumThe FlyCorbus Pharmaceuticals management to meet virtually with B. Riley
6d ago
CRBP
Corbus Pharmaceuticals Announces $70.5M Public Offering
Premium
Company Announcements
Corbus Pharmaceuticals Announces $70.5M Public Offering
9d ago
8K
CRBP
Corbus Pharmaceuticals 4.744M share Spot Secondary priced at $13.00
Premium
The Fly
Corbus Pharmaceuticals 4.744M share Spot Secondary priced at $13.00
12d ago
CRBP
Corbus Pharmaceuticals TBA Spot Secondary; price range $13.00-$14.00
PremiumThe Fly
Corbus Pharmaceuticals TBA Spot Secondary; price range $13.00-$14.00
13d ago
CRBP
Corbus Pharmaceuticals Announces Preliminary Q3 Financials
PremiumCompany Announcements
Corbus Pharmaceuticals Announces Preliminary Q3 Financials
13d ago
8K
CRBP
Corbus announces common stock and warrants offering, no amount given
PremiumThe Fly
Corbus announces common stock and warrants offering, no amount given
13d ago
CRBP
Corbus Pharmaceuticals price target raised to $39 from $32 at Mizuho
PremiumThe Fly
Corbus Pharmaceuticals price target raised to $39 from $32 at Mizuho
14d ago
CRBP
Corbus Pharmaceuticals Advances CRB-701 Clinical Study for Solid Tumors
PremiumCompany AnnouncementsCorbus Pharmaceuticals Advances CRB-701 Clinical Study for Solid Tumors
16d ago
CRBP
Corbus Pharmaceuticals’ CRB-601 Study: A New Hope for Advanced Solid Tumors
Premium
Company Announcements
Corbus Pharmaceuticals’ CRB-601 Study: A New Hope for Advanced Solid Tumors
16d ago
CRBP
Corbus Pharmaceuticals Presents Promising CRB-701 Study Results
Premium
Company Announcements
Corbus Pharmaceuticals Presents Promising CRB-701 Study Results
23d ago
8K
CRBP
Corbus Pharmaceuticals price target raised to $51 from $35 at Piper Sandler
PremiumThe Fly
Corbus Pharmaceuticals price target raised to $51 from $35 at Piper Sandler
23d ago
CRBP
Promising Trial Results and Market Potential Drive Buy Rating for Corbus Pharmaceuticals’ CRB-701
PremiumRatings
Promising Trial Results and Market Potential Drive Buy Rating for Corbus Pharmaceuticals’ CRB-701
23d ago
CRBP
Promising Potential of Corbus Pharmaceuticals’ CRB-701: A Best-in-Class ADC with Strong Safety and Efficacy
PremiumRatings
Promising Potential of Corbus Pharmaceuticals’ CRB-701: A Best-in-Class ADC with Strong Safety and Efficacy
23d ago
CRBP
Corbus Pharmaceuticals presents CRB-701 clinical responses at ESMO25
PremiumThe Fly
Corbus Pharmaceuticals presents CRB-701 clinical responses at ESMO25
24d ago
CRBP
Corbus Pharmaceuticals’ Promising CRB-701 Trial and Strategic Investor Engagement Justify Buy Rating
PremiumRatingsCorbus Pharmaceuticals’ Promising CRB-701 Trial and Strategic Investor Engagement Justify Buy Rating
27d ago
CRBP
Corbus Pharmaceuticals to present CRB-701 Phase 1/2 data at ESMO 2025
Premium
The Fly
Corbus Pharmaceuticals to present CRB-701 Phase 1/2 data at ESMO 2025
29d ago
CRBP
Optimistic Buy Rating for Corbus Pharmaceuticals Ahead of Promising CRB-701 Trial Results
Premium
Ratings
Optimistic Buy Rating for Corbus Pharmaceuticals Ahead of Promising CRB-701 Trial Results
1M ago
CRBP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >